A new survey conducted by the National Research Council and the American Association for the Advancement of Science queried scientists about their attitudes toward research that could be used for both good and evil.
According to an NRC statement, "rapid advances in the biological sciences over the last several decades have yielded great benefits such as medical therapies and vaccines. But some of these same scientific advances could also be used for malicious purposes, a threat that has become more salient to the science and policy communities since the terrorist attacks of 2001."
To that end, the survey "also explored actions the scientists might support to reduce the risk of misuse of research, as well as steps that scientists may already be taking in response to these concerns," the statement continues. The survey's results are summarized in a new NRC report that "includes recommendations for next steps."
While the survey had "a low response rate and uncertainties about whether the sample reflects the broader life sciences community limit the ability to generalize from the responses about the full U.S. life-sciences community” the survey results are nonetheless said to be “useful and informative," according to the statement.
The results suggest that survey respondents perceive a potential but not overwhelming risk of a bioterror attack in the next five years, a risk they believe is greater outside the U.S. Most respondents do not believe it is likely that dual-use knowledge, tools, or techniques will facilitate a bioterror attack in that time period.
Survey results also indicate that some respondents -- more than the committee had expected -- have been so concerned about dual-use issues that they have already taken action to try to avert misuse of research in the life sciences, even in the absence of guidelines or government restrictions. Some respondents reported that they had broken collaborations, not conducted some research projects, or not communicated research results.
Many of respondents' precautionary actions were taken during design, collaboration, and initial communication stages of research, before reaching the publication stage, the report notes. Of particular interest and concern to the committee, a few respondents offered comments about foreigners as potential security risks, which may be reflected in the reported avoidance of some collaborations.
"The fact that some scientists are changing their research activities may indicate that the life sciences community is responsibly responding to reduce the risk of misuse of science," said committee chair Ronald Atlas, professor of biology and public health at the University of Louisville. "But it is also possible that some scientists are overreacting to the perceived threat, for example by breaking collaborations and excluding foreigners from their laboratories. Our committee feels that it's important to further investigate how research activity is being changed in response to dual-use concerns."
With regard to future actions that the life sciences community would support to reduce the threat of misuse of research, the survey results indicate that life scientists in the U.S. may be more willing to consider mechanisms to reduce risks if they are developed and implemented by the scientific community itself. Most respondents favor their professional societies prescribing a code of conduct to help prevent misuse of life science research, for example, while a minority supported greater federal oversight. Among possible government restrictions, respondents were more supportive of restrictions on access to biological agents and certification of researchers than of any control of scientific knowledge generated from the research.
In addition, respondents showed support for mandatory training by institutions for practicing life scientists regarding dual-use concerns, as well as education materials and lectures for students.
The Carnegie Corp., the Alfred P. Sloan Foundation and the National Academies' Presidents' Circle Communications Initiative sponsored the project.
-- John Liang